Tuesday, November 5, 2024
Subscribe American Journal of Medicine Free Newsletter
dermatologyA Bad Sign: Dermatomyositis with Interstitial Lung Disease

A Bad Sign: Dermatomyositis with Interstitial Lung Disease

(A) A clinical examination revealed confluent symmetric violaceous patches on the malar eminences. (B) Additional violaceous patches were evident on the metacarpophalangeal joints. (C) Tender, erythematous papules marked the patient’s palms. (D) An ulcer (arrow) was noted on the antihelix. (E) A papule with a central ulcer was seen on the elbows.

The presence of an autoantibody explained why a patient with dermatomyositis had respiratory symptoms. A 52-year-old man presented with a 1-month history of fever and rash, and a 2-week history of muscle pain and muscle weakness, which made it difficult for him to rise from a sitting position. The patient denied being a smoker or taking any medicine regularly.

A physical examination revealed coarse crepitation in both lungs and proximal muscle weakness, grades III/IV. He had confluent, symmetric, violaceous patches on his scalp, malar eminences, the “V” area of the upper chest, the upper back, the third and fourth metacarpophalangeal joints, and the extensor tendons of both hands (Figures 1A and B). Multiple discrete, dull, erythematous papules marked his palms and fingers, and he had papules with central ulcers on the antihelices of his auricles and on his elbows (Figures 1C-E). Five days after admission to the hospital, his respiratory function began to decline. He developed progressive dyspnea with oxygen desaturation.

Assessment

Laboratory testing disclosed a creatine phosphokinase level of 1109 U/L (normal, 30-190 U/L) and an antinuclear antibody titer of 1:80 in a nucleolar pattern. Noncontrast computed tomography (CT) of the chest revealed predominant ground-glass opacity with traction bronchiectasis in both lower lobes (Figure 2). Anti-melanoma differentiation-associated gene 5 (MDA-5) autoantibody was detected in the patient’s serum.

To read this article in its entirety please visit our website.

-Siriwan Palawisuth, MDa,1, Kornphaka Kantikosum, MDa,1, Mattana Patiyasikunt, MDa, Thitiwat Sriprasart, MDb, Pravit Asawanonda, MD, DSca, Pawinee Rerknimitr, MD, MSca

This article originally appeared in the February issue of The American Journal of Medicine.

Latest Posts

lupus

Sarcoidosis with Lupus Pernio in an Afro-Caribbean Man

A 54-year-old man of Afro-Caribbean ancestry presented with a 2-month history of nonproductive cough, 10-day history of constant subjective fevers, and a 1-day history...
Flue Vaccine

Flu Vaccination to Prevent Cardiovascular Mortality (video)

0
"Influenza can cause a significant burden on patients with coronary artery disease," write Barbetta et al in The American Journal of Medicine. For this...
varicella zoster

Varicella Zoster Virus-Induced Complete Heart Block

0
Complete heart block is usually caused by chronic myocardial ischemia and fibrosis but can also be induced by bacterial and viral infections. The varicella...
Racial justice in healthcare

Teaching Anti-Racism in the Clinical Environment

0
"Teaching Anti-Racism in the Clinical Environment: The Five-Minute Moment for Racial Justice in Healthcare" was originally published in the April 2023 issue of The...
Invisible hand of the market

The ‘Invisible Hand’ Doesn’t Work for Prescription Drugs

0
Pharmaceutical innovation has been responsible for many “miracles of modern medicine.” Reliance on the “invisible hand” of Adam Smith to allocate resources in the...
Joseph S. Alpert, MD

New Coronary Heart Disease Risk Factors

0
"New Coronary Heart Disease Risk Factors" by AJM Editor-in Chief Joseph S. Alpert, MD was originally published in the April 2023 issue of The...
Cardiovascular risk from noncardiac activities

Cardiac Risk Related to Noncardiac & Nonsurgical Activities

0
"Assessment of Cardiovascular Risk for Noncardiac and Nonsurgical Activities" was originally published in the April 2023 issue of The American Journal of Medicine. Cardiovascular risk...